Effect of ertugliflozin on blood pressure in patients with type 2 diabetes mellitus: a post hoc pooled analysis of randomized controlled trials

Effect of ertugliflozin on blood pressure in patients with type 2 diabetes mellitus: a post hoc pooled analysis of randomized controlled trials

Abstract Background The efficacy of ertugliflozin, a sodium–glucose cotransporter 2 inhibitor, for glycemic and blood pressure (BP) control has been demonstrated in phase 3 studies. To further evaluate the effects of ertugliflozin on BP and other hemodynamic parameters, an analysis was conducted on...

Full description

Bibliographic Details
Main Authors: Jie Liu, Annpey Pong, Silvina Gallo, Amanda Darekar, Steven G. Terra
Format: Article
Language:English
Published: BMC 2019-05-01
Series:Cardiovascular Diabetology
Subjects:
Ertugliflozin
Sodium–glucose cotransporter 2 inhibitor
Blood pressure
Systolic blood pressure
Diastolic blood pressure
Pulse rate
Online Access:http://link.springer.com/article/10.1186/s12933-019-0856-7

Internet

http://link.springer.com/article/10.1186/s12933-019-0856-7

Similar Items